Trials / Completed
CompletedNCT00321230
Clinical Evaluation of a New Reduced Volume Bowel Preparation
A Pilot Monocentric, Open Phase II Study to Investigate the Efficacy and Safety of a New Oral Gut Cleansing Solution ("Low Dose Bowel Prep") in 30 Patients Submitted to Colonoscopy
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 30 (planned)
- Sponsor
- Norgine · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Monocentric, cleansing evaluation pilot study in patients undergoing colonoscopy.
Detailed description
Open prospective pilot monocentric phase II clinical trial evaluating the therapeutic efficacy of a new "Low Dose Bowel Prep" formulation for gut cleansing prior to colonoscopy. Thirty patients admitted to the hospital (inpatients) planned to undergo a complete colonoscopy will have gut cleansing with the "Low Dose Bowel Prep" using a one-step intake mode.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | macrogol3350 NA sulphate NACL KCL ascorbic acid NA ascorbate |
Timeline
- Start date
- 2001-01-01
- Completion
- 2001-05-01
- First posted
- 2006-05-03
- Last updated
- 2008-04-16
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT00321230. Inclusion in this directory is not an endorsement.